Marcolin records best-ever results

Fabrizio Curci, CEO and general manager of Marcolin

Shareholders are set to approve Marcolin’s best-ever sales results showing a 20.1 per cent increase on 2021 to the year ending 31 December 2022. Draft financial statements show net sales amounted to €547.4m in 2022.

Compared to 2021, the company improved its performance in all geographical areas – but most significantly in Asia (+ 47 per cent at current exchange rates and + 33 per cent at constant exchange rates). The EMEA region saw an 18 per cent increase in net sales at current exchange rates, and in the Americas a 17 per cent increase at current exchange rates.

Adjusted EBITDA reached €61m, showing an increase of 21.7 per cent compared to €50.1m in the previous year. The trend in the adjusted EBITDA margin reached 11.1 per cent of net sales.

Marcolin has attributed various factors to these results, including the consolidation of brands, the implementation of a digital transformation process, and a continuous push towards production and procurement efficiency.

The Italian firm’s net financial position amounted to €137.4m, an improvement of €10.7m compared to the previous year, thanks to the liquidity generated by both operating results and a regulated control of working capital in all its components, it said.

Fabrizio Curci, CEO and general manager of Marcolin, commented: “Last year confirmed how Marcolin is a high-performance and sound company capable of tackling a complex historical period with vision and far-sightedness while consolidating its leadership position among the reference players at global level in a sector that, today more than ever, is experiencing a moment of great dynamism and change.

“2022 results provide a drive for the company’s divisions to elevate our expectations even higher: the year ahead of us is just as challenging, but full of important events, in which we will have to prove once again that we are a modern, agile company, capable of reading economic trends and supporting a sector in which Italy acts as a leader.”

In 2022, Marcolin also gave further impetus to its commitment to sustainability and ESG issues through numerous corporate governance development actions, including obtaining ISO 13485 certification, which regulates quality management systems in the medical device sector internationally.